PL2578081T3 - Kompozycje, sposoby i urządzenia do leczenia chorób wątroby - Google Patents
Kompozycje, sposoby i urządzenia do leczenia chorób wątrobyInfo
- Publication number
- PL2578081T3 PL2578081T3 PL12176014.4T PL12176014T PL2578081T3 PL 2578081 T3 PL2578081 T3 PL 2578081T3 PL 12176014 T PL12176014 T PL 12176014T PL 2578081 T3 PL2578081 T3 PL 2578081T3
- Authority
- PL
- Poland
- Prior art keywords
- compositions
- methods
- devices
- liver disease
- treating liver
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M1/00—Suction or pumping devices for medical purposes; Devices for carrying-off, for treatment of, or for carrying-over, body-liquids; Drainage systems
- A61M1/34—Filtering material out of the blood by passing it through a membrane, i.e. hemofiltration or diafiltration
- A61M1/3472—Filtering material out of the blood by passing it through a membrane, i.e. hemofiltration or diafiltration with treatment of the filtrate
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
- A61K35/28—Bone marrow; Haematopoietic stem cells; Mesenchymal stem cells of any origin, e.g. adipose-derived stem cells
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M1/00—Suction or pumping devices for medical purposes; Devices for carrying-off, for treatment of, or for carrying-over, body-liquids; Drainage systems
- A61M1/34—Filtering material out of the blood by passing it through a membrane, i.e. hemofiltration or diafiltration
- A61M1/3472—Filtering material out of the blood by passing it through a membrane, i.e. hemofiltration or diafiltration with treatment of the filtrate
- A61M1/3486—Biological, chemical treatment, e.g. chemical precipitation; treatment by absorbents
- A61M1/3489—Biological, chemical treatment, e.g. chemical precipitation; treatment by absorbents by biological cells, e.g. bioreactor
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M1/00—Suction or pumping devices for medical purposes; Devices for carrying-off, for treatment of, or for carrying-over, body-liquids; Drainage systems
- A61M1/36—Other treatment of blood in a by-pass of the natural circulatory system, e.g. temperature adaptation, irradiation ; Extra-corporeal blood circuits
- A61M1/3687—Chemical treatment
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M1/00—Suction or pumping devices for medical purposes; Devices for carrying-off, for treatment of, or for carrying-over, body-liquids; Drainage systems
- A61M1/36—Other treatment of blood in a by-pass of the natural circulatory system, e.g. temperature adaptation, irradiation ; Extra-corporeal blood circuits
- A61M1/3687—Chemical treatment
- A61M1/3689—Chemical treatment by biological cells
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12M—APPARATUS FOR ENZYMOLOGY OR MICROBIOLOGY; APPARATUS FOR CULTURING MICROORGANISMS FOR PRODUCING BIOMASS, FOR GROWING CELLS OR FOR OBTAINING FERMENTATION OR METABOLIC PRODUCTS, i.e. BIOREACTORS OR FERMENTERS
- C12M29/00—Means for introduction, extraction or recirculation of materials, e.g. pumps
- C12M29/16—Hollow fibers
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
- C12N5/06—Animal cells or tissues; Human cells or tissues
- C12N5/0602—Vertebrate cells
- C12N5/0652—Cells of skeletal and connective tissues; Mesenchyme
- C12N5/0662—Stem cells
- C12N5/0663—Bone marrow mesenchymal stem cells (BM-MSC)
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
- C12N5/06—Animal cells or tissues; Human cells or tissues
- C12N5/0602—Vertebrate cells
- C12N5/067—Hepatocytes
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
- G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
- G01N33/5044—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics involving specific cell types
- G01N33/5067—Liver cells
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
- G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
- G01N33/5044—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics involving specific cell types
- G01N33/5073—Stem cells
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2502/00—Coculture with; Conditioned medium produced by
- C12N2502/13—Coculture with; Conditioned medium produced by connective tissue cells; generic mesenchyme cells, e.g. so-called "embryonic fibroblasts"
- C12N2502/1352—Mesenchymal stem cells
- C12N2502/1358—Bone marrow mesenchymal stem cells (BM-MSC)
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2500/00—Screening for compounds of potential therapeutic value
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2800/00—Detection or diagnosis of diseases
- G01N2800/08—Hepato-biliairy disorders other than hepatitis
- G01N2800/085—Liver diseases, e.g. portal hypertension, fibrosis, cirrhosis, bilirubin
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Biomedical Technology (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Heart & Thoracic Surgery (AREA)
- Cell Biology (AREA)
- Hematology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Vascular Medicine (AREA)
- Zoology (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Immunology (AREA)
- Biotechnology (AREA)
- Molecular Biology (AREA)
- Organic Chemistry (AREA)
- Wood Science & Technology (AREA)
- Anesthesiology (AREA)
- Genetics & Genomics (AREA)
- Microbiology (AREA)
- Biochemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Developmental Biology & Embryology (AREA)
- Medicinal Chemistry (AREA)
- Urology & Nephrology (AREA)
- General Engineering & Computer Science (AREA)
- Gastroenterology & Hepatology (AREA)
- Cardiology (AREA)
- Pharmacology & Pharmacy (AREA)
- Analytical Chemistry (AREA)
- General Physics & Mathematics (AREA)
- Tropical Medicine & Parasitology (AREA)
- Pathology (AREA)
- Food Science & Technology (AREA)
- Physics & Mathematics (AREA)
- Toxicology (AREA)
Applications Claiming Priority (4)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US85077806P | 2006-10-11 | 2006-10-11 | |
US85123406P | 2006-10-12 | 2006-10-12 | |
US92313807P | 2007-04-12 | 2007-04-12 | |
US99531607P | 2007-09-26 | 2007-09-26 |
Publications (2)
Publication Number | Publication Date |
---|---|
PL2578081T4 PL2578081T4 (pl) | 2016-09-30 |
PL2578081T3 true PL2578081T3 (pl) | 2016-09-30 |
Family
ID=39402354
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PL12176014.4T PL2578081T3 (pl) | 2006-10-11 | 2007-10-11 | Kompozycje, sposoby i urządzenia do leczenia chorób wątroby |
Country Status (7)
Country | Link |
---|---|
US (3) | US8172784B2 (pl) |
EP (2) | EP2076116A4 (pl) |
DK (1) | DK2578081T3 (pl) |
ES (1) | ES2583371T3 (pl) |
PL (1) | PL2578081T3 (pl) |
PT (1) | PT2578081E (pl) |
WO (1) | WO2008060788A2 (pl) |
Families Citing this family (30)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB0329449D0 (en) * | 2003-12-19 | 2004-01-28 | Omnicyte Ltd | Stem cells |
WO2008060788A2 (en) | 2006-10-11 | 2008-05-22 | The General Hospital Corporation | Compositions, methods, and devices for treating liver disease |
US20110190680A1 (en) | 2008-09-29 | 2011-08-04 | Yoram Vodovotz | Self-Regulating Device for Modulating Inflammation |
GB0818725D0 (en) * | 2008-10-13 | 2008-11-19 | Habib Nagy A | Pharmaceutical composition |
US20130197893A1 (en) | 2010-06-07 | 2013-08-01 | University Of Pittsburgh - Of The Commonwealth System Of Higher Education | Methods for modeling hepatic inflammation |
CN102641297B (zh) * | 2011-02-21 | 2016-02-24 | 杨子江 | 治疗外周动脉粥样硬化引起的缺血性疾病的制剂及其制备方法 |
CN102641292B (zh) * | 2011-02-21 | 2015-11-25 | 杨子江 | 促血管及周边组织修复或再生的制剂及其制备方法 |
CN102641293B (zh) * | 2011-02-21 | 2016-02-24 | 杨子江 | 用于治疗缺血性脑血管疾病的制剂及其制备方法 |
CA2829586C (en) * | 2011-03-11 | 2021-03-02 | Children's Medical Center Corporation | Methods and compositions relating to mesenchymal stem cell exosomes |
EP2508607A1 (en) * | 2011-04-07 | 2012-10-10 | Helmholtz-Zentrum für Infektionsforschung GmbH | Medicament for liver regeneration and for treatment of liver failure |
ES2526816B1 (es) * | 2013-06-14 | 2015-10-27 | Fundación Pública Andaluza Progreso Y Salud | Composiciones para el tratamiento del daño hepático |
US20160129047A1 (en) | 2013-07-05 | 2016-05-12 | Université Catholique de Louvain | Conditioned medium from human adult liver stem cells and its use in the treatment of liver disorders |
CA2949083C (en) | 2014-05-18 | 2023-10-10 | Children's Medical Center Corporation | Methods and compositions relating to exosomes |
ES2573354B1 (es) * | 2014-11-06 | 2017-03-24 | Servicio Andaluz De Salud | Lisados de células madre mesenquimales para el tratamiento de lesiones músculo esqueléticas |
JP6663445B2 (ja) | 2015-04-01 | 2020-03-11 | サンバイオ,インコーポレイティド | 細胞増殖の刺激のための方法及び組成物、ならびにfgf2アイソフォームの生物学的に活性な混合物の提供 |
US11291689B2 (en) | 2015-06-03 | 2022-04-05 | Aelan Cell Technologies, Inc. | Methods and devices for the production and delivery of beneficial factors from adipose-derived stem cells |
AU2016279985A1 (en) * | 2015-06-15 | 2018-01-18 | Vital Therapies, Inc. | Composition and method for inducing anti-apoptosis, survival, or proliferation of a cell |
US20180220642A1 (en) * | 2015-07-29 | 2018-08-09 | Indiana University Research And Technology Corporation | Materials and methods for treating and evaluating ischemic and/or reperfusion-injured tissue and/or tissue susceptible to same |
US10328122B2 (en) * | 2015-09-15 | 2019-06-25 | Zhejiang University | Method of treating fulminant hepatic failure using DLL4 cytokine |
SG10201913909XA (en) | 2016-08-02 | 2020-03-30 | Angel Playing Cards Co Ltd | Inspection system and management system |
WO2018081524A1 (en) * | 2016-10-28 | 2018-05-03 | Vital Therapies, Inc. | Use of conditioned media from extracorporeal blood detoxifying system to supplement organ perfusion solutions |
JP6950887B2 (ja) * | 2017-04-28 | 2021-10-13 | 米満 吉和 | 体外型の人工肝臓、及び体外型の人工肝臓用又は肝細胞培養用の器具 |
GB2568928B (en) * | 2017-12-01 | 2023-03-08 | Young Cell Biomedical Tech Inc | Neuroprotective composition, preparation process thereof and medical uses thereof |
GB2618001B (en) * | 2018-02-20 | 2024-01-31 | Emulate Inc | Human microphysiological cell system for liver disease |
US20210395691A1 (en) * | 2018-11-09 | 2021-12-23 | Figene, Llc | Means and methods of preventing or reversing aging |
CA3156906A1 (en) * | 2019-11-20 | 2021-05-27 | Alkahest, Inc. | Blood plasma fractions for use in liver regeneration |
EP4036221A1 (en) * | 2021-01-29 | 2022-08-03 | Baer, Hans Ulrich | Method for stimulating cell growth and proliferation of cells of interest, and method for preparing a liver or pancreas implant |
CN113016778A (zh) * | 2021-02-08 | 2021-06-25 | 广东乾晖生物科技有限公司 | 基于间充质干细胞的离体器官灌注保存系统 |
CN113082337A (zh) * | 2021-02-23 | 2021-07-09 | 广东乾晖生物科技有限公司 | 基于胎盘间充质干细胞生物反应器的生物人工肝支持系统 |
CN117568437A (zh) * | 2021-08-30 | 2024-02-20 | 四川大学 | 一种基于生物埃米孔检测药物分子的方法 |
Family Cites Families (44)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4522811A (en) | 1982-07-08 | 1985-06-11 | Syntex (U.S.A.) Inc. | Serial injection of muramyldipeptides and liposomes enhances the anti-infective activity of muramyldipeptides |
US4833083A (en) * | 1987-05-26 | 1989-05-23 | Sepragen Corporation | Packed bed bioreactor |
US5605835A (en) * | 1988-05-23 | 1997-02-25 | Regents Of The University Of Minnesota | Bioreactor device with application as a bioartificial liver |
US5602026A (en) * | 1988-10-14 | 1997-02-11 | The General Hospital Corporation | Culturing liver cells between two supports |
EP0532522B1 (en) * | 1990-05-16 | 1996-04-10 | Baylor College Of Medicine | A permanent human hepatocyte cell line and its use in a liver assist device (lad) |
US5270192A (en) | 1991-02-07 | 1993-12-14 | Monsanto Company | Biological artificial liver |
US5549674A (en) * | 1992-03-02 | 1996-08-27 | The Regents Of The University Of Michigan | Methods and compositions of a bioartificial kidney suitable for use in vivo or ex vivo |
AU7959494A (en) | 1992-09-11 | 1996-04-19 | Xenogenex, Inc. | Artificial liver apparatus and method |
US5866420A (en) * | 1993-10-08 | 1999-02-02 | The United States Of America As Represented By The Secretary Of Agriculture | Artificial liver device |
US6472200B1 (en) | 1999-07-23 | 2002-10-29 | Yissum Research Development Company Of The Hebrew University Of Jerusalem | Device and method for performing a biological modification of a fluid |
US6372495B1 (en) * | 1995-10-06 | 2002-04-16 | Seed Capital Investments-2 (Sci-2) B.V. | Bio-artificial organ containing a matrix having hollow fibers for supplying gaseous oxygen |
US6287558B1 (en) | 1997-08-01 | 2001-09-11 | Biohybrio Technologies Llc | Devices containing cells or tissue and an agent that inhibits damage by a host cell molecule |
US6429012B1 (en) | 1997-10-06 | 2002-08-06 | Viacell, Inc. | Cell population containing non-fetal hemangioblasts and method for producing same |
AUPP108597A0 (en) * | 1997-12-22 | 1998-01-22 | Sheil, A G R Prof. | Liver support system |
US6328960B1 (en) | 1998-03-18 | 2001-12-11 | Osiris Therapeutics, Inc. | Mesenchymal stem cells for prevention and treatment of immune responses in transplantation |
US6060364A (en) * | 1999-03-02 | 2000-05-09 | Advanced Micro Devices, Inc. | Fast Mosfet with low-doped source/drain |
WO2000064510A1 (en) * | 1999-04-23 | 2000-11-02 | Nephros Therapeutics, Inc. | Extracorporeal circuit and related methods |
US7759113B2 (en) | 1999-04-30 | 2010-07-20 | The General Hospital Corporation | Fabrication of tissue lamina using microfabricated two-dimensional molds |
US6372494B1 (en) | 1999-05-14 | 2002-04-16 | Advanced Tissue Sciences, Inc. | Methods of making conditioned cell culture medium compositions |
JP4605734B2 (ja) | 1999-06-21 | 2011-01-05 | ザ ジェネラル ホスピタル コーポレイション | 臓器補助装置のための細胞培養システム及び方法 |
WO2000078920A1 (en) * | 1999-06-21 | 2000-12-28 | The General Hospital Corporation | Methods and devices for cell culturing and organ assist systems |
US6861001B2 (en) * | 1999-12-02 | 2005-03-01 | The General Hospital Corporation | Methods for removal, purification, and concentration of viruses, and methods of therapy based thereupon |
ES2300320T3 (es) * | 2000-02-26 | 2008-06-16 | Artecel, Inc. | Celulas madre pluripotentes generadas a partir de celulas del estroma derivadas de tejido adiposo y sus usos. |
WO2002030267A2 (en) | 2000-10-12 | 2002-04-18 | Renal Solutions, Inc. | Devices and methods for body fluid flow control in extracorporeal fluid treatments |
US7311905B2 (en) | 2002-02-13 | 2007-12-25 | Anthrogenesis Corporation | Embryonic-like stem cells derived from post-partum mammalian placenta, and uses and methods of treatment using said cells |
JP2004529621A (ja) | 2001-02-14 | 2004-09-30 | ティー ファークト,レオ | 多能性成体幹細胞、その起源、それを得る方法および維持する方法、それを分化させる方法、その使用法、ならびにそれ由来の細胞 |
US6582955B2 (en) * | 2001-05-11 | 2003-06-24 | Spectrum Laboratories, Inc. | Bioreactor with application as blood therapy device |
US6607501B2 (en) * | 2001-05-14 | 2003-08-19 | Reynolds G. Gorsuch | Process and apparatus for utilization of in vivo extracted plasma with tissue engineering devices, bioreactors, artificial organs, and cell therapy applications |
US6620630B2 (en) | 2001-09-24 | 2003-09-16 | Extraction Systems, Inc. | System and method for determining and controlling contamination |
US20050008626A1 (en) * | 2001-12-07 | 2005-01-13 | Fraser John K. | Methods of using adipose tissue-derived cells in the treatment of cardiovascular conditions |
JP4355212B2 (ja) | 2001-12-21 | 2009-10-28 | オーガノジェネシス インコーポレーテッド | 細胞培養及び臓器補助用の可変容量チャンバ |
WO2003080649A2 (en) * | 2002-03-20 | 2003-10-02 | Regents Of The University Of Minnesota | Induction of hepatocyte proliferation in vitro by inhibition of cell cycle inhibitors |
US7160719B2 (en) * | 2002-06-07 | 2007-01-09 | Mayo Foundation For Medical Education And Research | Bioartificial liver system |
EP1608411B1 (en) | 2003-04-01 | 2010-09-29 | United States Government as represented by the Department of Veteran's Affaires | Stem-cell, precursor cell, or target cell-based treatment of multi-organ failure. |
JPWO2005024004A1 (ja) * | 2003-08-27 | 2006-11-02 | 株式会社レノメディクス研究所 | 間葉系幹細胞の肝細胞への分化方法及び人工ヒト肝臓細胞 |
WO2005074657A2 (en) | 2004-02-02 | 2005-08-18 | The General Hospital Corporation | Modified organ support devices |
CN101080486B (zh) | 2004-04-23 | 2012-05-16 | 佰欧益股份有限公司 | 多谱系祖细胞 |
US7622108B2 (en) | 2004-04-23 | 2009-11-24 | Bioe, Inc. | Multi-lineage progenitor cells |
AU2005240515B2 (en) * | 2004-04-27 | 2010-09-23 | Vital Therapies, Inc. | Metabolic detoxification system and method |
CA2585740A1 (en) | 2004-10-28 | 2006-05-11 | Medivas, Llc | Bioactive wound dressings and implantable devices and methods of use |
BRPI0520280A2 (pt) | 2005-05-10 | 2009-04-28 | Us Of America Dept Of Veteran | terapia de disfunÇÕes renais e falÊncia méltipla de àrgços com cÉlulas-tronco mesenquimais e meio condicionado por exposiÇço a cÉlulas-tronco mesenquimais |
US20070065415A1 (en) | 2005-09-16 | 2007-03-22 | Kleinsek Donald A | Compositions and methods for the augmentation and repair of defects in tissue |
NZ568618A (en) * | 2005-12-29 | 2011-10-28 | Anthrogenesis Corp | Co-culture of placental stem cells and stem cells from a second source |
WO2008060788A2 (en) | 2006-10-11 | 2008-05-22 | The General Hospital Corporation | Compositions, methods, and devices for treating liver disease |
-
2007
- 2007-10-11 WO PCT/US2007/081142 patent/WO2008060788A2/en active Application Filing
- 2007-10-11 US US11/871,071 patent/US8172784B2/en not_active Expired - Fee Related
- 2007-10-11 PL PL12176014.4T patent/PL2578081T3/pl unknown
- 2007-10-11 EP EP07868423A patent/EP2076116A4/en not_active Withdrawn
- 2007-10-11 ES ES12176014.4T patent/ES2583371T3/es active Active
- 2007-10-11 DK DK12176014.4T patent/DK2578081T3/en active
- 2007-10-11 PT PT121760144T patent/PT2578081E/pt unknown
- 2007-10-11 EP EP12176014.4A patent/EP2578081B1/en active Active
-
2012
- 2012-04-30 US US13/460,315 patent/US20120225130A1/en not_active Abandoned
-
2015
- 2015-12-11 US US14/967,028 patent/US10363276B2/en active Active
Also Published As
Publication number | Publication date |
---|---|
EP2578081B1 (en) | 2016-03-09 |
ES2583371T3 (es) | 2016-09-20 |
DK2578081T3 (en) | 2016-06-27 |
US20120225130A1 (en) | 2012-09-06 |
WO2008060788A2 (en) | 2008-05-22 |
EP2578081A2 (en) | 2013-04-10 |
EP2578081A3 (en) | 2013-04-24 |
US10363276B2 (en) | 2019-07-30 |
EP2076116A4 (en) | 2010-04-07 |
US20160331784A1 (en) | 2016-11-17 |
PL2578081T4 (pl) | 2016-09-30 |
PT2578081E (pt) | 2016-06-17 |
US20080145442A1 (en) | 2008-06-19 |
EP2076116A2 (en) | 2009-07-08 |
WO2008060788A3 (en) | 2008-12-04 |
US8172784B2 (en) | 2012-05-08 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EP2076116A4 (en) | COMPOSITIONS, METHODS AND DEVICES FOR THE TREATMENT OF LIVER DISEASES | |
IL291175A (en) | Compositions and methods for treating collagen-mediated diseases | |
IL257681A (en) | Methods and compositions for the treatment of cancer | |
EP1959929A4 (en) | COMPOSITIONS AND METHODS FOR TREATING DERMATOLOGICAL SUFFERING | |
HK1125868A1 (en) | Compositions and methods for treating bone | |
IL195619A0 (en) | Compositions and methods for joininig non-conjoined iumens | |
IL193014A0 (en) | Methods and compositions for treating schizophrenia | |
EP2170309A4 (en) | METHOD AND COMPOSITIONS FOR THE TREATMENT OF DISEASES | |
HK1137670A1 (en) | Compositions and methods for arthrodetic procedures | |
EP2124985A4 (en) | METHOD AND COMPOSITIONS FOR TREATING NERVOUS ELEMENTS | |
GB0601143D0 (en) | Uses, methods and compositions | |
AP2011005681A0 (en) | Methods and formulations for treating chronic liver disease. | |
ZA200900140B (en) | Methods and compositions for treating biofilms | |
HUP0700369D0 (en) | Pharmaceutical compositions and method for treating schizofrenia | |
EP1971354A4 (en) | LIQUIRITIGENIN-BASED COMPOSITION FOR THE PREVENTION AND TREATMENT OF HEPATIC DISEASES | |
EP1855662A4 (en) | METHODS AND COMPOSITIONS FOR TREATING CANCER | |
ZA200806361B (en) | Methods and compositions for treating feline hyperthyroidism | |
HK1129596A1 (en) | Methods and compositions for treating disease | |
EP2094279A4 (en) | METHOD AND COMPOSITIONS FOR THE TREATMENT OF INFLUENZA | |
EP2170314A4 (en) | METHODS AND COMPOSITIONS FOR THE TREATMENT OF PHENYLCETONURIA | |
GB0712671D0 (en) | Compounds, compositions and processes | |
EP2068629A4 (en) | COMPOSITIONS AND METHODS FOR TREATING CANCER | |
ZA201001779B (en) | Compositions and methods for treating collagen-mediated diseases | |
GB0522732D0 (en) | Composition and method for treating disease | |
GB0507963D0 (en) | Composition and method for treating disease |